hit counter

Resting Brain Connectivity Predicts Fear Extinction Learning

Photoreal illustration of brain network connections in the fear-extinction circuitry, with imagery linking amygdala and prefrontal regions.

A 2026 multimodal MRI analysis of 509 healthy adults found that fear acquisition, extinction learning, and renewal were not predicted by one generic “fear circuit” score: functional connectivity predicted acquisition, structural connectivity predicted extinction, and effective connectivity was the only renewal signal.1 The extinction result is the clinically interesting piece because exposure therapy depends on …

Read more

Psychedelic Hallucinations May Reflect Wake-Time Memory Replay

Photoreal illustration of a brain shifting between perception and generative imagery under psychedelic influence.

A 2026 eLife computational study modeled classical psychedelics by increasing a network state variable from alpha = 0 to alpha = 1, shifting perception from bottom-up sensory inference toward top-down generative replay. The result is a useful but still unproven oneirogen model: hallucinations look less like random noise and more like wake-time replay of a …

Read more

EEG Alpha Density Decreased in Children, Increased in Adults

Photoreal illustration of children and adults with overlay of EEG brain rhythms, conveying developmental differences in sleep effects on brain activity.

A 2026 eNeuro analysis of 163 people ages 3.5–24.7 found that wake EEG amplitude behaved like a sleep-pressure marker, but wake alpha-density changed in opposite directions across development: it decreased overnight in children and increased overnight in adolescents and adults.1 Research Highlights Alpha density flipped by age: In 163 participants ages 3.5–24.7, oscillation density showed …

Read more

Posttraumatic Growth in Farsi Refugees: 61% Explained by 4 Factors

Photoreal illustration of refugees in community setting with imagery of resilience and growth, conveying integrated trauma adaptation.

A 2026 survey of 230 Farsi-speaking refugees in German camps found a hard double signal: 69.1% screened above the RHS-15 threshold for depression, anxiety, and PTSD symptoms, while 4 protective factors explained 61% of posttraumatic-growth variance.1 Research Highlights High distress and growth coexisted: 159 of 230 participants (69.1%) scored ≥12 on the RHS-15 symptom scale, …

Read more

Cannabis After Pregnancy Did Not Increase Hypertension Risk in nuMoM2b

Photoreal illustration of a postpartum woman with stethoscope and cannabis imagery, conveying cardiovascular implications of postpartum cannabis use.

A 2026 nuMoM2b Heart Health Study analysis tested whether urine-confirmed cannabis exposure 2–7 years after a first pregnancy predicted incident stage II hypertension; it did not: adjusted odds ratio (AOR) 1.05, 95% CI 0.63–1.76, with 216 of 4,079 participants developing hypertension.1 Research Highlights The headline result was null: cannabis exposure at the 2–7 year postpartum …

Read more

Chronic Pain Plus Depression Alters Brain Structure

Photoreal illustration of brain regions affected by overlapping pain and depression networks, conveying comorbid neural signature.

A 2026 UK Biobank MRI preprint involving 71,214 adults found that chronic pain plus current depression had a structural brain profile that was more than chronic pain plus depression pasted together. The 1,377-person comorbid group showed widespread lower cortical volume, lower bilateral thalamic and hippocampal volume, lower left accumbens volume, and broad white-matter microstructure differences …

Read more

Methylphenidate Reduced Dishonesty and Cheating in 151 Adults; Atomoxetine Had No Effect

Editorial card showing methylphenidate molecular structure beside a die-rolling task, illustrating a counterintuitive randomized-trial result.

A 2026 double-blind randomized controlled trial by Kappes et al. in Psychopharmacology found something the smart-drug users likely wouldn’t have predicted: a single 30 mg dose of methylphenidate reduced dishonest misreporting on a die-rolling task from ~22% of trials in the placebo arm to ~6% (in the methylphenidate arm).1 Atomoxetine, a noradrenergic comparator, had no …

Read more